Hana Securities sells three power plants acquired by SK E&S... The sale price is expected to be around 1 trillion won

Reporter Kim Jisun / approved : 2023-08-31 03:00:53
  • -
  • +
  • 인쇄
 

 

[Alpha Biz=(Chicago) Reporter Kim Jisun] Hana Securities has been confirmed to be in the process of selling three regional power plants acquired from SK E&S in the past.

According to the financial investment industry on the 30th, Hana Securities recently selected Samjeong KPMG, an accounting firm, as an advisor to the sale and is looking for three acquisition candidates: Pyeongtaek Energy Service, Gimcheon Energy Service and Jeonbuk Group Energy.

The industry expects this sale price to be over 1 trillion won,

"The target of the sale is a local power plant with monopolistic status, and we understand that the price calculated according to the multiple, which is usually applied by related industries, is around 1 trillion won," said an official at Hana Securities Co.

"We expect the sale by the end of this year, but it can vary depending on market conditions," he added.

Earlier in late 2014, Hana Securities (then Hana Investment & Securities) signed a stock trading contract with SK E&S to take over shares and management rights of three power plants in question as a package.

The acquisition was conducted through Hana Securities' private equity fund (PEF) "Hana Power Infrastructure No. 1 private equity investment company."

At that time, the assets of the three power plants were about 1.2 trillion won, and the actual equity transaction was about 500 billion won.

 

Alphabiz Reporter Kim Jisun(stockmk2020@alphabiz.co.kr)

어플

주요기사

Dongwon F&B Ordered to Revise Unfair Dealer Contract Terms2025.12.23
Coupang Files Lawsuit Challenging Industrial Accident Ruling in Death of Warehouse Worker2025.12.23
Cho Hyun-bum, Chairman of Hankook & Company, Sentence Reduced to Two Years on Embezzlement and Breach of Trust Charges2025.12.23
Korea’s Tax Authority Launches Special Tax Probe into Coupang2025.12.23
Samsung Biologics Acquires GSK’s U.S. Biopharmaceutical Facility to Mitigate Tariff Risks and Expand Production Capacity2025.12.23
뉴스댓글 >

건강이 보이는 대표 K Medical 뉴스

HEADLINE

PHOTO

많이 본 기사